Basics
Description
- Primarily for depression
- Selegiline, a selective monoamine oxidase B inhibitor, is sometimes used to treat Parkinson disease, and also comes in a transdermal preparation.
- Monoamine oxidase inhibitor (MAOI) pharmacologic actions:
- Disruption of equilibrium between endogenous monoamine synthesis and degradation, resulting in:
- Increased neural norepinephrine levels
- Downregulation of several receptor types
- Inhibition of irreversible (noncompetitive) enzyme
- Inhibition of other B6-containing enzymes
- MAO: Principal inactivator of neural bioactive amines:
- MAO A:
- Present in the gut and liver
- Protects against dietary bioactive amines
- MAO B:
- Present in neuron terminals and platelets
- Sympathomimetic amines: Types of bioactive amines
Etiology
- MAOI overdose:
- Toxicopharmacology poorly understood
- MAO inhibitors: Amphetamine-like in structure:
- Early: Indirect sympathomimetic effect
- Late: Sympatholytic response (hypotension)
- MAOI hypertensive crisis syndrome:
- Results from impaired norepinephrine degradation and large norepinephrine release precipitated by an indirect- or mixed-acting sympathomimetic agent
- Common precipitants: Tyramine, cocaine, amphetamines
- Serotonin syndrome (SS):
- Commonly results from exposure to combinations of agents that affect serotonin metabolism or action
- Increases serotonin synthesis: Tryptophan
- Increase serotonin release:
- Indirect- and mixed-acting sympathomimetic agents and dopamine receptor agonists
- Decrease serotonin reuptake:
- Selective serotonin reuptake inhibitors
- Tricyclic antidepressants
- Newer antidepressants: Trazodone, nefazodone, venlafaxine
- Phenylpiperidine opioids: Meperidine, dextromethorphan, tramadol, methadone, propoxyphene
- Direct serotonin receptor agonists:
- Buspirone, sumatriptan, lysergic acid diethylamide
- Decrease serotonin breakdown:
- Increases nonspecific serotonin activity:
Diagnosis
Signs and Symptoms
- MAOI overdose:
- Delayed onset (6 " 12 hr)
- Initial hypertension with headache
- Hyperadrenergic activity:
- Tachycardia
- Hypertension
- Mydriasis
- Agitation
- Neuromuscular excitation:
- Nystagmus
- Hyperreflexia
- Tremor
- Myoclonus
- Rigidity
- Seizures
- Hyperthermia
- Associated complications:
- Rhabdomyolysis
- Renal failure
- Disseminated intravascular coagulation (DIC)
- Acute respiratory distress syndrome (ARDS)
- MAOI hypertensive crisis syndrome (MAOI interaction with drug or food):
- Hypertension
- Tachycardia or bradycardia
- Hyperthermia
- Headache, usually occipital
- Altered mental status
- Intracranial hemorrhage
- Seizures
- SS:
- Increased neuromuscular activity
- Increased deep tendon reflexes:
- Lower extremity may be greater than upper
- Tremor
- Myoclonus
- Rigidity (when severe)
- Autonomic nervous system hyperactivity:
- CNS:
- Agitation
- Hallucinations
- Delirium
- Coma
- Diarrhea
- SS vs. neuroleptic malignant syndrome (NMS):
- Both present along a spectrum of severity (mild to severe)
- Onset: Hours (SS) vs. days (NMS)
- Gastrointestinal symptoms: May be present (SS) vs. absent (NMS)
- Only drug/medication history may differentiate in many cases
History
- Time of ingestion
- Bottle available
- Intentional or accidental
- Coingestions
Physical Exam
- Neuromuscular hyperactivity:
- Myoclonus
- Rigidity
- Tremors
- Hyperreflexia
- Autonomic hyperactivity:
- Tachycardia or bradycardia
- Fever
- Diaphoresis
- Altered mental status:
- Agitation, confusion, or excitement
Essential Workup
- History of ingested substances
- Rectal temperature monitoring as indicated
- Blood pressure/cardiac monitoring
Diagnosis Tests & Interpretation
Lab
- Urinalysis:
- Electrolytes, BUN/creatinine, glucose:
- Hypoglycemia may contribute to altered mental status.
- Acidosis may accompany severe toxicity.
- Rhabdomyolysis may cause renal failure.
- Hyperkalemia " life-threatening consequence of acute renal failure
- Coagulation profile to monitor for potential DIC:
- INR, prothrombin time, partial thromboplastin time, platelets
- Creatinine kinase:
- Markedly elevated in rhabdomyolysis
- Urine toxicology screen:
- May be positive for amphetamines, given the structural similarities between some MAOIs and amphetamines
- Aspirin and acetaminophen levels if suicide attempt a possibility
- Arterial blood gas
Imaging
- Chest radiograph:
- Head CT if significant headache or altered mental status or focal neurologic signs:
- Subarachnoid hemorrhage, intracerebral bleed
Diagnostic Procedures/Surgery
Lumbar puncture for:
- Suspected meningitis (headache, altered mental status, hyperpyrexia)
- Suspected subarachnoid hemorrhage and CT normal
Differential Diagnosis
- Hyperthermia:
- Infection
- Hyperthyroidism
- Heat stroke
- Anatomic thalamic dysfunction
- NMS
- Malignant hyperthermia
- Malignant catatonia
- Ethanol or drug withdrawal
- Anticholinergic toxicity
- Sympathomimetic overdose
- Cocaine-associated delirium/rhabdomyolysis
- Salicylate toxicity
- Theophylline toxicity
- Nicotine toxicity
- Hypertension:
- Hypoglycemia
- Carcinoid syndrome
- Pheochromocytoma
- Accelerated renovascular hypertension
- Ethanol or drug withdrawal
- Sympathomimetic toxicity
Treatment
Pre-Hospital
- Patient may be uncooperative or violent.
- Secure IV access.
- Protect from self-induced trauma.
Initial Stabilization/Therapy
- Airway, breathing, and circulation (ABCs)
- IV access and fluid resuscitation if hypotensive
- Oxygen
- Cardiac monitor
- Naloxone, thiamine, D50W (or Accu-Chek) if altered mental status
Ed Treatment/Procedures
- Gastrointestinal decontamination:
- In potential life-threatening ingestions gastric lavage may be carefully considered if within 1 hr of ingestion
- Administer activated charcoal
- Hyperthermia:
- Benzodiazepines if agitated
- Active cooling if temperature >40 °C:
- Tepid water mist
- Evaporate with fan
- Paralysis:
- Indicated if muscle rigidity and hyperactivity contributing to persistent hyperthermia
- Nondepolarizing agent (e.g., vecuronium)
- Avoid succinylcholine
- Intubation; mechanical ventilation
- Administer acetaminophen.
- Apply cooling blankets.
- Severe, malignant hypertension:
- Nitroprusside (for MAOI overdose)
- Calcium-channel blocker or phentolamine (for MAOI + food interaction)
- Use short-acting IV agent that can be rapidly "turned off. "
- Hypotension:
- Initially bolus with isotonic crystalloid solution
- If no response, administer norepinephrine.
- Dopamine may be ineffective
- Dysrhythmias (premorbid sign in MAOI overdose):
- Treatment based on dysrhythmia
- Seizures:
- Benzodiazepines
- Barbiturates if benzodiazepines unsuccessful
- Pyridoxine for refractory seizures
- Rigidity:
- Benzodiazepines
- Paralysis with vecuronium, endotracheal intubation, and mechanical ventilation
- ARDS:
- Oxygen
- Intubation and positive end-expiratory pressure as indicated
- DIC:
- Fresh-frozen plasma
- Platelets
- Whole-blood transfusions
- Rhabdomyolysis:
- IV isotonic crystalloid solution
- Maintain hydration to ensure adequate urine output
- Specific treatment for SS:
- Mainstay: Supportive care, discontinuation of offending agents
- Nonselective serotonin antagonist:
Phentolaminecontraindicated in MAOI overdose (results in unopposed ²-agonist)
Medication
- Activated charcoal: 1 " 2 g/kg PO
- Cyproheptadine: 4 " 8 mg PO/nasogastric tube q1 " 4h until therapeutic response; max. daily dose: 0.5 mg/kg (peds: 0.25 mg/kg/d; max. 12 mg/d; safety not established age <2 yr)
- Dextrose: D50W 1 " 2 amp (50 " 100 mL or 25 " 50 g) (peds: D25W 2 " 4 mL/kg) IV push (IVP)
- Diazepam: 5 " 10 mg (peds: 0.1 mg/kg slowly) increments IVP
- Lorazepam: 1 " 2 mg increments IVP
- Nitroprusside: 0.3 " 10 Ό/kg/min IV
- Norepinephrine: 2-4 Ό/kg/min (peds: 0.05 " 0.1 Ό/kg/min) IV
- Phentolamine: 5 mg (peds: 0.05 " 0.2 mg/kg/dose) increments IVP
- Sodium bicarbonate: Bolus 1 " 2 mEq/kg IVP; adult infusion: 3 amp (50 mEq per amp) sodium bicarbonate in 1,000 mL D5W at 2 " 3 mL/kg/h IV
- Vecuronium: 0.1 mg/kg IVP
Follow-Up
Disposition
MAOI toxicity can occur in delayed fashion necessitating an extended observation period
Admission Criteria
- All MAOI overdose patients require admission to a monitored unit for 24 hr.
- ICU admission for seriously ill patients
Discharge Criteria
- Resolved mild hypertensive syndrome or resolved mild serotonin syndrome may be discharged after several hours of ED observation.
Issues for Referral
Intentional overdoses should receive a psychiatry consult for suicide attempt.
Followup Recommendations
Following significant MAOI toxicity, medications need to be reassessed to prevent future crises.
Pearls and Pitfalls
- Delayed onset of 6 " 12 hr prior to symptoms
- Linezolid and methylene blue are MAOIs.
- Phentolamine is contraindicated in MAOI overdose secondary to unopposed ²-agonist.
Additional Reading
- Boyer EW, Shannon M. The serotonin syndrome. New Engl J Med. 2005;352:1112 " 1120.
- Brush DE, Bird SB, Boyer EW. Monoamine oxidase inhibitor poisoning resulting from Internet misinformation on illicit substances. J Toxicol Clin Toxicol. 2004;42:191 " 195.
- Gillman PK. Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity. Br J Anaesth. 2005;95:434 " 441.
- Oates JA, Sjoerdsma A. Neurologic effects of tryptophan in patients receiving a monoamine oxidase inhibitor. Neurology. 1960;10:1076 " 1078.
- Ramsay RR, Dunford C, Gillman PK. Methylene blue and serotonin toxicity: Inhibition of monoamine oxidase A (MAO A) confirms a theoretical prediction. Br J Pharmacol. 2007;152:946 " 951.
See Also (Topic, Algorithm, Electronic Media Element)
Sympathomimetic Poisoning
Codes
ICD9
969.01 Poisoning by monoamine oxidase inhibitors
ICD10
- T43.1X1A Poisoning by monoamine-oxidase-inhibitor antidepressants, accidental (unintentional), initial encounter
- T43.1X2A Poisoning by monoamine-oxidase-inhibitor antidepressants, intentional self-harm, initial encounter
- T43.1X4A Poisoning by MAO inhib antidepressants, undetermined, init
SNOMED
- 9291000 Poisoning by monoamine oxidase inhibitor (disorder)
- 295889000 Overdose of monoamine oxidase inhibitor antidepressant drug (disorder)
- 216548005 Accidental poisoning by monoamine oxidase inhibitors (disorder)